ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells (Q40657593)
scientific article published on April 2003
Language:
(P31) (Q13442814)
(P50) (Q6279267)
(Q125261309)
(Q125261496)
(Q125261612)
(P304) 1274-1283
(P407) (Q1860)
(P433) 4
(P478) 9
(P577) Tuesday, April 1, 2003
(P921) (Q61643320)
(P1433) (Q332253)
(P1476) "ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells" (language: en)
(P2093) Pablo Matar
Marta Guzmán
Federico Rojo
Joaquin Arribas
other details
description scientific article published on April 2003

External Links